APATINIB

Clinical trials for APATINIB explained in plain language.

Never miss a new study

Get alerted when new APATINIB trials appear

Sign up with your email to follow new studies for APATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for bile duct cancer: triple therapy shows promise after chemo fails

Disease control Completed

This Phase 2 trial tested a combination of three treatments—local chemotherapy delivered via beads into the liver, a targeted drug called apatinib, and an immunotherapy (PD-1 antibody)—in 20 patients with advanced bile duct cancer that had worsened after standard first-line chemo…

Matched conditions: APATINIB

Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

APATINIB

Get alerted when new APATINIB trials appear

New hope for bile duct cancer: triple therapy shows promise after chemo fails